CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands	3 Months Ended	6 Months Ended
Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Revenues:
Total revenues	$ 882	$ 29	$ 1,186	$ 50
Operating expenses:
Cost of goods sold	17		17
Research and development	30,779	35,490	60,152	62,709
Selling, general and administrative	39,419	16,490	66,484	29,384
Total operating expenses	70,215	51,980	126,653	92,093
Loss from operations	(69,333)	(51,951)	(125,467)	(92,043)
Interest income	5,332	4,738	9,571	8,591
Interest expense	(3,319)	(2,003)	(6,752)	(3,925)
Other income and (expense), net	(63)	(11)	(125)	28
Net loss	$ (67,383)	$ (49,227)	$ (122,773)	$ (87,349)
Basic net loss per share	$ (0.1)	$ (0.09)	$ (0.19)	$ (0.16)
Diluted net loss per share	$ (0.1)	$ (0.09)	$ (0.19)	$ (0.16)
Shares used in computing basic net loss per share	653,904,978	547,280,946	628,699,214	553,772,809
Shares used in computing diluted net loss per share	653,904,978	547,280,946	628,699,214	553,772,809
Product Revenue, Net
Revenues:
Total revenues	$ 780		$ 780
Royalties
Revenues:
Total revenues	$ 102	$ 29	$ 406	$ 50

The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.

Name:	us-gaap_EarningsPerShareBasic
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:perShareItemType
Balance Type:	na
Period Type:	duration

- Definition

The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.